AI-generated · cited to primary sources · not investment advice
Balaji Amines (530999) Jun 2025 Filing Analysis
Does management do what it says?
The company reported total volumes of 27,570 MT for Q1FY26, which is a 6.5% increase over Q4FY25 (25,871 MT). While showing growth, it is too early to confirm the full-year target of 10-12%. (1 in progress, 1 revised, 1 met across 3 tracked commitments)
“We are expecting minimum 10% to 12% of the volume growth.”
The INR 750 crore expansion is progressing. Unit 1 brownfield is expected by September 2026, and Unit 2 greenfield is expected by December 2026. (1 in progress across 1 tracked commitment)
“New expansion of approx. Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited... The Greenfield project... will be commissioned during the end of the FY 2025-26.”
See the full cited Management analysis of Balaji Amines
How durable is the business?
Amines volumes increased to 8,316 MT in Q4FY25 from 7,746 MT in the prior period, though the overall segment revenue share remains under pressure due to pricing headwinds in the broader chemical industry. (3 expanding, 1 contracting, 1 stable)
“Amines volumes stood at 8,316 MT”
Specialty chemical volumes contracted to 9,167 MT in Q4 FY25 compared to 10,660 MT previously, primarily due to Chinese dumping and volatility in the agrochemical sector. (1 contracting)
“specialty chemical volumes stood at 9,167 metric tons.”
See the full cited Business Model analysis of Balaji Amines
Where does growth come from?
The Rs. 750 crore expansion in Balaji Speciality Chemicals is progressing with environmental clearances cleared and commissioning expected by end of FY 2025-26. (1 steady, 1 accelerating across 2 signals)
“New expansion of approx. Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited... will be commissioned during the end of the FY 2025-26.”
The project for doubling ACN capacity to 60 MT/Day is in the engineering and equipment ordering phase, with commissioning targeted for FY 2026-27. (2 steady across 2 signals)
“upgradation of technology and increasing the capacity of existing ACN plant to a capacity of 60 MT/Day... plant will be commissioned during the FY 2026-27.”
See the full cited Future Growth analysis of Balaji Amines
What could break the thesis?
The risk is intensifying as management admits they will likely consume all cash surpluses this year and may need to take on an additional INR 50-150 crores in debt by FY27 to finish expansions. (2 intensifying)
“This year, we'll be consuming both cash as well as surplus... we may go INR50 crores, INR100 crores only for the debt by '27... maybe INR100 crores, INR150 crores we may require in subsidiary level.”
Raw material costs as a percentage of revenue remain high (approx 54-60% on standalone basis), and the company continues to flag sourcing as a key industry challenge. (1 stable, 1 intensifying, 1 easing)
“Ability to pass on raw material price volatility to its customers and thus maintain healthy & stable EBITDA margins”
See the full cited Risk analysis of Balaji Amines
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.